TheraRadar
← Back
Data updated: Mar 29, 2026

BRECKENRIDGE PHARM

CardiovascularNeurologyImmunology
Generics

BRECKENRIDGE PHARM is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology.

2006
Since
42
Drugs
-
Trials
367
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

RIVAROXABAN 2026-02-20
ZOLEDRONIC ACID 2026-02-05
METHADONE HYDROCHLORIDE 2026-01-22
Manufacturing (CMC)
ACETAZOLAMIDE 2026-01-12
Labeling
AMITRIPTYLINE HYDROCHLORIDE 2026-01-09
Labeling
EVEROLIMUS 2026-01-09
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 33%
3 drugs
Neurology 22%
2 drugs
Immunology 22%
2 drugs
Ophthalmology 11%
1 drugs
Respiratory 11%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular, Immunology, Ophthalmology, Respiratory
Roche big-pharma
Neurology, Ophthalmology, Immunology, Respiratory
AbbVie big-pharma
Immunology, Neurology, Ophthalmology
UPJOHN big-pharma
Neurology, Cardiovascular, Immunology, Ophthalmology
GSK big-pharma
Respiratory, Immunology, Neurology